Dr. Danka Svecova, Medicine Doctor (PhD. – dermatology), now is a professor of Dermatovenerology, Head of Bullous Disorders Unit at Dept. of Dermatovenerology, University Hospital and Faculty of Medicine, Comenius University in Bratislava, Slovakia. She is a board member of Committee for Dermatovenerology and Immunology Dissertation for PhD. at Comenius University in Bratislava. She is a member of committee for Probation of Specialization for Dermatovenerology at Comenius University in Bratislava and University of J.P. Safarik in Kosice. At Hokkaido University in Sapporo, Japan, she participated in research on Skin Allergology and Immunology under the supervision of Professor Akira Ohkawara. She attended Good Clinical Practice Guideline Course of the International Conference on Harmonization at Royal Holloway University of London, UK. She held several grant projects on fungal infection, therapy of psoriasis, borreliosis (the cooperation with University of Oxford, UK, under supervision of Professor Michael Donaghy), immunomodulatory and anti-inflammatory efficacy of normal polyphenols, immunogenetic determination to psoriasis vulgaris and pemphigus vulgaris, clinical trial of anti-IL17A/F bispecific nanobody in psoriasis vulgaris (multicentric European study), GWAS (Genome wide association study) on pemphigus vulgaris (the cooperation with Anhui Medical University in China and Harvard Medical School in U.S.A. under supervision of Professor Liangdan Sun) and role of Th17 in pathogenesis of psoriasis vulgaris. She wrote two monographs about blistering disorders “Pemphigus Vulgaris Autoimmune Disease†(Nova Science Publishers, New York, U.S.A.) and “Pemphigus†(Bonus, Bratislava, Slovakia).
